Form 8-K - Current report:
SEC Accession No. 0001193125-24-286244
Filing Date
2024-12-30
Accepted
2024-12-30 09:00:54
Documents
19
Period of Report
2024-12-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d855930d8k.htm   iXBRL 8-K 29441
2 EX-99.1 d855930dex991.htm EX-99.1 17981
7 GRAPHIC g855930g1230044338835.jpg GRAPHIC 5594
8 GRAPHIC g855930g1230044339091.jpg GRAPHIC 844
9 GRAPHIC g855930g1230044339257.jpg GRAPHIC 854
10 GRAPHIC g855930g1230044339437.jpg GRAPHIC 964
  Complete submission text file 0001193125-24-286244.txt   229151

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241230.xsd EX-101.SCH 4467
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241230_def.xml EX-101.DEF 13883
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241230_lab.xml EX-101.LAB 23225
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241230_pre.xml EX-101.PRE 14852
22 EXTRACTED XBRL INSTANCE DOCUMENT d855930d8k_htm.xml XML 6183
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241587042
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)